跳至主要内容
临床试验/CTRI/2024/03/064152
CTRI/2024/03/064152尚未招募Unknown

PRECEDE: The Pancreatic Cancer Early Detection Consortium - Precede

Arbor research collaborative for Health0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • Individuals from the following groups who present for clinical evaluation and assessment of PDAC risk at Max Super speciality hospital can be offered participation in the PRECEDE database:
  • Individuals without history of PDAC meeting any of the following criteria:
  • 1. 2+ relatives with PDAC on same side of family where 2 affected are first degree related to each other and at least 1 affected is first degree related to subject; age 50+ or =10 years younger than earliest PDAC in family at time of diagnosis.
  • 2. 2 affected first degree relatives with PDAC; age 50+ or 10 years younger than earliest PDAC in family
  • 3. BRCA1, BRCA2, PALB2, ATM, MLH1, MSH2, MSH6, PMS2, EPCAM pathogenic or likely pathogenic variant AND 1 first or second degree relative with PDAC; age 50+ or 10 years younger than earliest PDAC in family
  • 4. Familial Atypical Moles and Malignant Melanoma (FAMMM) with pathogenic or likely pathogenic CDKN2A variant; age 40+
  • 5. Peutz-Jegher syndrome with STK11 pathogenic or likely pathogenic variant; age 35+
  • 6. Hereditary pancreatitis with PRSS1 pathogenic or likely pathogenic variant and history of pancreatitis; age 40+
  • Individuals without history of PDAC meeting any of the following criteria:
  • 1. ATM, BRCA1, BRCA2, or PALB2 pathogenic or likely pathogenic variant regardless of family history, age 50+
  • 2. 2+ relatives with PDAC on the same side of family, any degree of relation, not meeting other criteria above; age 50+ or 10 years younger than earliest PDAC in family
  • 3. 1 first degree relative with PDAC = age 45; age up to 10 years younger than PDAC diagnosis in family member
  • Individual meeting criteria for Cohorts 1 or 2 EXCEPT age (i.e. too young to qualify for Cohorts 1 or 2)
  • Individuals without history of PDAC presenting for evaluation who do not meet any criteria for 1-3, 6, or the Cyst Cohort.
  • Individuals who are not otherwise engaged in pancreas surveillance at a participating site may be invited to participate in the PRECEDE database and to donate a biosample (e.g. blood, saliva, and/or buccal swab) for discovery studies. This may include relatives of individuals in Cohorts 1-4, 6, and the Cyst Cohort.
  • Individuals with a personal history of PDAC meeting any of the following criteria:
  • 1. Family history includes at least one first degree relative with PDAC, or 2 relatives with PDAC who are first degree related to each other
  • 2. Personal or family history of a pathogenic or likely pathogenic germline variant in ATM, BRCA1, BRCA2, CDKN2A, EPCAM, MLH1, MSH2, MSH6, PALB2,PMS2, PRSS1, STK11
  • 3. Diagnosed = age 45
  • Cyst Cohort
  • Individuals with a personal history of a pancreatic cystic neoplasm not meeting any criteria for Cohorts 1-3 or 6 (no known family history of PDAC, no known pathogenic germline variants linked to PDAC risk)

排除标准

  • 未提供

研究者

相似试验